The Clindamycin Hydrochloride Capsul, cataloged under National Stock Number 6505-01-290-4628, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Mylan Pharmaceuticals Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-290-4628 |
| Primary Part Number | NDC59762-5010-02 |
| Item Name | Clindamycin Hydrochloride Capsul |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Mylan Pharmaceuticals Inc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 100.000 |
| Capsule Type | HARD |
| Capsule Content Form | GRANULE |
| Active Medicament Medicinal Strength | 300.000 MILLIGRAMS CLINDAMYCIN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC59762-5010-02 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| CLEOCIN HCL | 5/1 Secondary reference U.S. Government activity |
| NDC00009-0395-14 | 3/2 Design control — primary reference U.S. Government activity |
| NDC00009-0395-14 | 3/9 Design control — primary reference Pfizer Pharmaceuticals |
NSN 6505-01-290-4628 is a Clindamycin Hydrochloride Capsul, manufactured by Mylan Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-290-4628 has 1 manufacturer part number on file: NDC59762-5010-02 (Mylan Pharmaceuticals Inc).
Key specifications for NDC59762-5010-02: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 100.000; Capsule Type: HARD. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.